Pharmaceutical manufacturer Uni-Pharma SA announced on Thursday the distribution of 24 million doses of chloroquine-based drug Unikinon to Greek hospitals, with a batch of 60,000 doses to be sent to Cyprus.
According to the announcement, Unikinon was approved by the National Organization for Medicines for distribution as of today Friday 3 April, to all coronavirus reference hospitals of the National Health System.
Some 24 million doses of Unikinon will be distributed and a batch of 60,000 doses will be sent to Cyprus.
In a statement, Uni-Pharma SA clarified that the purchase of five tons for the active ingredient of Unikinon was a company initiative, and it paid for the expenditure entirely on its own. The purchase of the ingredient took place on March 21, it said.
A company statement on its site said that chloroquine, along with hydroxychloroquine, are being researched globally as therapy for Covid-19, “but their effectiveness in cure Covid-19 remains under review through studies.”
